Johnson & Johnson receives FDA IDE approval for OTTAVA robotic surgical system
J&J received FDA IDE approval for OTTAVA, authorizing U.S. clinical trial of the robotic surgical system.
Evidence notes
- Johnson & Johnson MedTech received FDA investigational device exemption approval for OTTAVA.
- The approval allowed the company to begin a U.S. clinical trial of the robotic surgical system.
- The milestone preceded the first completed OTTAVA cases and later FDA submission.
Company context
Johnson & Johnson is a global healthcare company with surgical robotics exposure through OTTAVA and Monarch within its medtech business.